Teladoc Inc (NYSE:TDOC) has been assigned an average rating of “Buy” from the twelve ratings firms that are currently covering the stock, Market Beat Ratings reports. Two equities research analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $35.17.

A hedge fund recently bought a new stake in Teladoc stock. Jennison Associates acquired a new stake in shares of Teladoc Inc (NYSE:TDOC) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 1,423,322 shares of the company’s stock, valued at approximately $31,726,000. Jennison Associates owned approximately 3.70% of Teladoc at the end of the most recent reporting period.

TDOC has been the subject of several research analyst reports. Zacks Investment Research upgraded Teladoc from a “sell” rating to a “hold” rating in a research note on Monday, September 28th. Deutsche Bank restated a “buy” rating and issued a $34.00 price objective on shares of Teladoc in a research note on Friday, October 2nd. Wells Fargo restated a “buy” rating on shares of Teladoc in a research note on Sunday, October 4th. William Blair restated a “buy” rating on shares of Teladoc in a research note on Sunday, October 4th. Finally, Leerink Swann restated a “buy” rating on shares of Teladoc in a research note on Monday, October 5th.

Teladoc (NYSE:TDOC) opened at 17.44 on Tuesday. The stock’s market capitalization is $670.62 million. The company has a 50-day moving average price of $18.35 and a 200-day moving average price of $22.16. Teladoc has a 12-month low of $15.00 and a 12-month high of $35.42.

Teladoc (NYSE:TDOC) last announced its quarterly earnings data on Monday, November 2nd. The company reported ($0.35) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.35). The firm earned $19.97 million during the quarter, compared to analysts’ expectations of $19.31 million. During the same quarter in the previous year, the business earned ($1.14) earnings per share. The company’s revenue for the quarter was up 83.0% compared to the same quarter last year. Analysts expect that Teladoc will post ($1.59) earnings per share for the current fiscal year.

Teladoc, Inc. is a telehealth company. The Company offers an on-demand healthcare platform, through mobile devices, Internet, video and phone. Its solution connects consumers with physicians and behavioral health professionals or its providers, who treat various conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation. The Teladoc solution enables accessing on-demand healthcare for employers, health plans and health systems. Its platform provides accessing physicians, clinical programs and consumer engagement strategies. Its platform provides for interconnectivity between healthcare constituents. It offers solutions, such as remote patient monitoring, post-discharge treatment plan adherence and in-home and chronic care. Its customers also include channel partners such as brokers, resellers and consultants who sell into a range of small, medium and large enterprises.

12 Month Chart for NYSE:TDOC

Receive News & Ratings for Teladoc Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc and related companies with MarketBeat.com's FREE daily email newsletter.